The Ebola outbreak declared in August 2018 was the worst ever documented in Democratic Republic of Congo (DRC)—and the second-largest Ebola outbreak recorded anywhere. Efforts to stop the spread of the disease were challenged on many fronts, including by the realities of fighting an epidemic in a conflict zone.
DRC’s Ministry of Health officially declared a new outbreak of Ebola virus disease in North Kivu on August 1, 2018. It was the country's tenth outbreak of the deadly virus in 40 years.
买球电脑版On July 17, 2019, the declared the Ebola outbreak in Democratic Republic of Congo to be a public health emergency of international concern.
On June 25, 2020, the outbreak was officially declared over. There were 3,470 cases, 2,287 deaths, and 1,171 survivors.
Just as this outbreak was winding down, DRC's 11th Ebola outbreak was declared in Equateur province买球电脑版, on the opposite end of a vast country. MSF has sent teams to help curb the spread of the disease, support community surveillance, and provide rapid treatment to patients living in remote areas. Some health zones are very hard to reach and only accessible by river using canoes or after hours of difficult transport by rough roads through the forest.
The latest on Ebola in DRC
At the request of the Ministry of Health (MoH), Doctors Without Borders/Médecins Sans Frontières (MSF) is part of the national task force coordinating the intervention based on several pillars of the Ebola response. As of January 27, 2019, MSF had received 3,292 people at its Ebola treatment centers and transit centers in the affected region. We have treated a total of 321 patients confirmed with Ebola. MSF has also vaccinated more than 4,800 frontline health workers, who are among those at greatest risk of contracting the disease.
Medical activities have been suspended at MSF's Ebola treatment centers in Butembo and Katwa after the facilities were attacked by unidentified assailants in late February. MSF has evacuated staff from the area for their safety pending a thorough analysis of the risks associated with continuing to provide medical care there.
Violence and political unrest
买球电脑版The epicenter of the Ebola outbreak is in North Kivu, a densely populated area in the country’s northeast. North Kivu shares a border with Uganda and is a hub for travel and trade, as well as human trafficking. North Kivu has also been an area of conflict for over 25 years, with more than 100 armed groups active in the region.
买球电脑版As the number of new confirmed Ebola cases continues to grow, violence and political unrest in the affected areas have further restricted the community’s access to health care. Security constraints are hindering the Ebola response, making it difficult to identify new cases, trace contacts, and conduct vital community outreach activities. Some health centers have been damaged or temporarily closed.
“In this situation people might have no other choice than to seek medical help in health facilities that do not have adequate triage or infection prevention and control measures in place, which makes the risk of contamination higher,” said Laurence Sailly, MSF emergency coordinator in Beni. “We are talking about a population that has endured many years of conflict. On top of that, they are now faced with the deadliest Ebola outbreak the country has ever seen. The unrest … adds even more to their plight by limiting their chances of finding adequate medical care.”
On February 24, 2019, unidentified assailants attacked the MSF-managed Ebola treatment center in Katwa, setting the structure on fire and destroying medical wards and equipment. Three days later MSF's Butembo treatment center was also attacked and burned. All medical activities at the two sites have been suspended.
买球电脑版At our Ebola treatment centers, MSF teams worked to increase the level of supportive care—ensuring proper hydration, providing treatment for malaria and other co-infections, as well as treatment of the symptoms of Ebola. Our clinicians also now have the ability to use experimental therapeutics under various mechanisms, including compassionate care protocols and participation in a randomized controlled trial. The four experimental therapeutics being used in the trial are Remdesivir (GS5734), REGN3470-3471-3479, ZMapp, and mAb114. These treatments are given only with the informed consent of the patient (or a family member, if the patient is too young or too sick) and are provided in addition to supportive care.